The Spine in β-thalassemia syndromes
Axillary lymph node ratio revisited
Deferiprone or deferasirox for cardiac siderosis in beta-thalassemia major
Effects of divalproex sodium on hemoglobin level
Clinicovirologic analysis of hepatitis C infection in transfusion-dependent β-thalassemia major children
Brain positron emission tomography in splenectomized adults with β-thalassemia intermedia: Uncovering yet another covert abnormality
Optimal management of β thalassaemia intermedia
Iron chelation therapy for non-transfusion-dependent thalassemia (NTDT): A status quo
Longitudinal changes in serum ferritin levels correlate with measures of hepatic stiffness in transfusion-independent patients with β-thalassemia intermedia
Age-related complications in treatment-naïve patients with thalassaemia intermedia
Elevated liver iron concentration is a marker of increased morbidity in patients with β thalassemia intermedia
Switching patients from warfarin to dabigatran therapy: To RE-LY or not to rely
Managing unresponsiveness or intolerance to deferasirox therapy: A tale of two doses
Does absolute excess of alpha chains compromise the benefit of splenectomy in patients with thalassemia intermedia?
Carbamazepine-induced thrombocytopenia
Iron and hepatitis C: What can we learn from thalassemia major?
To the editor
Evaluation of the 5mg-g liver iron concentration threshold and its association with morbidity in patients with β-thalassemia intermedia